Mounjaro Insurance Coverage

Direct Answer

Mounjaro is covered for type 2 diabetes broadly across commercial and Medicare plans, since that's its actual FDA-approved indication, with standard prior authorization (HbA1c 7.0%+ and a documented metformin trial). Mounjaro is not FDA-approved for weight loss, Zepbound is the approved weight-management version of the same active ingredient, tirzepatide, and insurers generally evaluate them separately based on the specific indication prescribed.

A Real, Important Distinction

Mounjaro and Zepbound need genuinely separate coverage answers even though both contain tirzepatide, they're different products with different approved uses, and a Mounjaro coverage result doesn't answer a Zepbound question, or vice versa.

Coverage varies by specific plan, employer, and state. This information reflects publicly available data as of August 2026.

Browse Coverage by Payer

• UnitedHealthcare GLP-1 Insurance Coverage
• Blue Cross Blue Shield GLP-1 Insurance Coverage
• Aetna GLP-1 Insurance Coverage
• Cigna GLP-1 Insurance Coverage
• Humana GLP-1 Insurance Coverage
• Medicare GLP-1 Insurance Coverage
• Medicaid GLP-1 Insurance Coverage

Browse All Insurance Coverage

See the complete GLP-1 Insurance Coverage hub

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com